Probably next week?Next week looks like "the first half" of February ? The company expects that the mice will be challenged with (exposed to) the COVID-19 virus at the end of the month followed by careful monitoring and testing. Vaxil Bio said it expects to provide further updates in the first half of February 2021. Vaxil Bio's Chairman and CEO David Goren said the study is proceeding as planned. "Mice were successfully vaccinated, and we have detected an antigen-specific T cell response in several of the animals receiving the vaccine candidate." In addition, Vaxil has completed its exploratory oral experiment announced in December 2020. In this very preliminary experiment, Vaxil was able to establish that it is possible to observe an immune response in some animals after oral delivery of the vaccine candidate. No ticket, no win Best to all